These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8621845)
21. The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma. Dal Negro RW; Micheletto C; Tognella S; Trevisan F; Guerriero M Eur Ann Allergy Clin Immunol; 2006 May; 38(5):153-7. PubMed ID: 17058847 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma. Medley H; Orozco S; Allen A Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247 [TBL] [Abstract][Full Text] [Related]
23. Comparison of different long-term asthma treatments in subjects with mild-to-moderate asthma. Di Franco A; Giannini D; Bacci E; Dente FL; Vagaggini B; Paggiaro PL Monaldi Arch Chest Dis; 1999 Oct; 54(5):390-3. PubMed ID: 10741095 [TBL] [Abstract][Full Text] [Related]
24. Steroid sparing effect of nedocromil sodium in asthmatic patients on high doses of inhaled steroids. Wong CS; Cooper S; Britton JR; Tattersfield AE Clin Exp Allergy; 1993 May; 23(5):370-6. PubMed ID: 8392897 [TBL] [Abstract][Full Text] [Related]
25. Nedocromil sodium in obstructive airways disease: effect on symptoms and plasma protein leakage in sputum. Schoonbrood DF; Out TA; Hart AA; Habets FJ; Roos CM; Jansen HM Eur Respir J; 1997 Jul; 10(7):1500-6. PubMed ID: 9230237 [TBL] [Abstract][Full Text] [Related]
26. A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment? Schwartz HJ; Blumenthal M; Brady R; Braun S; Lockey R; Myers D; Mansfield L; Mullarkey M; Owens G; Ratner P; Repsher L; van As A Chest; 1996 Apr; 109(4):945-52. PubMed ID: 8635375 [TBL] [Abstract][Full Text] [Related]
27. Comparison of two different dose regimens of nedocromil sodium with placebo in the management of childhood asthma. Sekerel BE; Saraçlar Y; Etikan I; Kalayci O J Investig Allergol Clin Immunol; 1999; 9(5):293-8. PubMed ID: 10582197 [TBL] [Abstract][Full Text] [Related]
28. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir. Cass LM; Gunawardena KA; Macmahon MM; Bye A Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424 [TBL] [Abstract][Full Text] [Related]
29. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily]. Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083 [TBL] [Abstract][Full Text] [Related]
30. The effect of nedocromil sodium on childhood asthma during the viral season. König P; Eigen H; Ellis MH; Ellis E; Blake K; Geller D; Shapiro G; Welch M; Scott C Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1879-86. PubMed ID: 8520750 [TBL] [Abstract][Full Text] [Related]
31. Quality of life, symptoms and pulmonary function in asthma. A year-long multicentre double-blind trial of nedocromil sodium versus placebo. Levenstein JH Fam Pract; 1991 Dec; 8(4):402-3. PubMed ID: 1666057 [No Abstract] [Full Text] [Related]
32. High-dose nedocromil sodium as an addition to inhaled corticosteroids in the treatment of asthma. O'Hickey SP; Rees PJ Respir Med; 1994 Aug; 88(7):499-502. PubMed ID: 7972972 [TBL] [Abstract][Full Text] [Related]
33. Nedocromil in the outpatient management of asthma. Keenan JM; Bielory L; Flamion PC; Ford LB; Murcek M; Pyszczynski DR; Selcow J; Silvagni A; Tarpay M; Zitt MJ Arch Fam Med; 1995 Oct; 4(10):835-42; discussion 843. PubMed ID: 7551130 [TBL] [Abstract][Full Text] [Related]
34. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Wenzel S; Castro M; Corren J; Maspero J; Wang L; Zhang B; Pirozzi G; Sutherland ER; Evans RR; Joish VN; Eckert L; Graham NM; Stahl N; Yancopoulos GD; Louis-Tisserand M; Teper A Lancet; 2016 Jul; 388(10039):31-44. PubMed ID: 27130691 [TBL] [Abstract][Full Text] [Related]
35. A double-blind group comparative trial of nedocromil sodium and placebo in the management of bronchial asthma. Fairfax AJ; Allbeson M J Int Med Res; 1988; 16(3):216-24. PubMed ID: 2842206 [TBL] [Abstract][Full Text] [Related]
36. Antiasthmatic effects of nedocromil sodium. Gazdik F; Jahnova E; Horvathova M; Pijak MR; Gazdikova K Bratisl Lek Listy; 2003; 104(7-8):222-6. PubMed ID: 15168867 [TBL] [Abstract][Full Text] [Related]
37. Ambulatory long-term subcutaneous salbutamol infusion in chronic severe asthma. Cluzel M; Bousquet J; Daures JP; Renon D; Clauzel AM; Godard PH; Michel FB J Allergy Clin Immunol; 1990 Mar; 85(3):599-606. PubMed ID: 2179366 [TBL] [Abstract][Full Text] [Related]
38. Double-blind crossover study of nedocromil sodium in partially reversible chronic obstructive airways disease. Tandon MK Chest; 1993 Jan; 103(1):105-10. PubMed ID: 8380266 [TBL] [Abstract][Full Text] [Related]
39. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626 [TBL] [Abstract][Full Text] [Related]
40. Effectiveness of nedocromil sodium versus placebo as additions to routine asthma maintenance therapy: a multicentre, double-blind, group comparative trial. Bianco S; Del Bono N; Grassi V; Orefice U Respiration; 1989; 56(3-4):204-11. PubMed ID: 2561409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]